|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.30 EUR | -0.13% |
|
+3.34% | -4.80% |
| 02:37am | Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO | RE |
| 06-11 | European Equities Traded in US as ADRs Rise in Thursday Trading | MT |
Company Valuation: BioNTech SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 54,749 | 34,159 | 22,698 | 26,387 | 19,497 | 19,505 | - | - |
| Change | - | -37.61% | -33.55% | 16.25% | -26.11% | 0.04% | - | - |
| Enterprise Value (EV) 1 | 53,358 | 20,496 | 11,253 | 16,879 | 12,356 | 8,653 | 10,224 | 9,429 |
| Change | - | -61.59% | -45.1% | 50% | -26.8% | -29.97% | 18.16% | -7.78% |
| P/E Ratio | 5.72x | 3.72x | 24.9x | -39.7x | -17.3x | -17.5x | -17.2x | -19.7x |
| PBR | 4.62x | 1.7x | 1.12x | - | 1.06x | 1.08x | 1.19x | 1.28x |
| PEG | - | -0.79x | -0.3x | 0x | -0.2x | 2.78x | -11.21x | 1.6x |
| Capitalization / Revenue | 2.89x | 1.97x | 5.94x | 9.59x | 6.79x | 9.01x | 8.74x | 7.73x |
| EV / Revenue | 2.81x | 1.18x | 2.95x | 6.14x | 4.31x | 4x | 4.58x | 3.74x |
| EV / EBITDA | 3.47x | 1.61x | 12.9x | -16.6x | -12.1x | -6.98x | -7.93x | -9.65x |
| EV / EBIT | 3.49x | 1.62x | 16.3x | -12.8x | -8.79x | -5.73x | -6.7x | -7.56x |
| EV / FCF | 72.5x | 1.55x | 2.41x | -69x | 44x | -5.57x | -8.18x | -11.7x |
| FCF Yield | 1.38% | 64.5% | 41.5% | -1.45% | 2.27% | -18% | -12.2% | -8.55% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 39.63 | 37.77 | 3.83 | -2.77 | -4.7 | -4.404 | -4.472 | -3.919 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,977 | 17,311 | 3,819 | 2,751 | 2,870 | 2,166 | 2,231 | 2,523 |
| EBITDA 1 | 15,359 | 12,766 | 873.8 | -1,016 | -1,022 | -1,240 | -1,289 | -977 |
| EBIT 1 | 15,284 | 12,643 | 690.4 | -1,314 | -1,405 | -1,511 | -1,526 | -1,247 |
| Net income 1 | 10,292 | 9,434 | 930.3 | -665.3 | -1,136 | -1,051 | -1,165 | -959 |
| Net Debt 1 | -1,391 | -13,663 | -11,445 | -9,508 | -7,141 | -10,852 | -9,281 | -10,076 |
| Reference price 2 | 226.68 | 140.56 | 95.48 | 110.06 | 81.08 | 77.13 | 77.13 | 77.13 |
| Nbr of stocks (in thousands) | 241,521 | 243,019 | 237,716 | 239,740 | 240,455 | 252,884 | - | - |
| Announcement Date | 3/30/22 | 3/27/23 | 3/20/24 | 3/10/25 | 3/10/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32x | 8.3x | 25.1x | 0.06% | 54.54B | ||
| 16.43x | 4.93x | 10.71x | 1.83% | 43.86B | ||
| -36.18x | 11.93x | -34.8x | -.--% | 20.7B | ||
| 19.54x | 3.8x | 9.87x | -.--% | 15.84B | ||
| 20.6x | 4.16x | 13.77x | -.--% | 14.83B | ||
| 16.47x | 4.75x | 11.13x | -.--% | 13.1B | ||
| -444.13x | 30.23x | -3370.59x | -.--% | 12.66B | ||
| -72.96x | 7.37x | -66.11x | -.--% | 11.56B | ||
| 38.53x | 14.84x | 43.58x | -.--% | 11.68B | ||
| Average | -45.52x | 10.03x | -373.04x | 0.21% | 22.08B | |
| Weighted average by Cap. | -17.46x | 8.76x | -207.85x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Valuation BioNTech SE
Select your edition
All financial news and data tailored to specific country editions
















